Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats-Reference-Cited by-同舟云学术

Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats

Published:2009 Issue:15 Volume:15 Page:1821
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Zhang Hai-Qiang,Ding Tomas T,Zhao Jun-Sheng,Yang Xin,Zhang Hai-Xia,Zhang Juan-Juan,Cui Yun-Long

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference46 articles.

1. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002;8:158-161.

2. Jiang XL, Quan QZ, Wang ZK. Diagnosis, Clinical types and criteria of effectiveness of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2000;8:332-334.

3. Wang QY, Chen CL, Sun Y, Zhang LL, Liu MJ, Pan LJ. Study the flora analysis result of the ulcertive colitis patients. Zhongguo Weishengtaixue Zazhi 2002;4:31-32.

4. Ou-yang Q, Liang HL. Ulcertive Colitis. Jixu Yixue Jiaoyu 2006;20:30-34.

5. Sasakil M, Arakil Y, Tsujikawa T, Andoh A, Fujiyama Y. Intestinal Cell Proliferation and Microflora. Journal of Intestinal Microbiology 2005;19:1-8.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Arginine-Vasopressin Receptor 1a (Avpr1a/Avpr1a) as a Novel Candidate Gene for Chronic Visceral Pain Sheds Light on the Potential Role of Enteric Neurons in the Development of Visceral Hypersensitivity;The Journal of Pain;2024-09

2. Live and Dead Clostridium butyricumGKB7 Diminish Osteoarthritis Pain and Progression in Preclinical Animal Model;Environmental Toxicology;2024-06-25

3. Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways;International Immunopharmacology;2024-05

4. The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV;Probiotics and Antimicrobial Proteins;2024-02-09

5. An evaluation of animal models for using bioactive compounds in the treatment of inflammatory bowel disease;Food Frontiers;2024-02-05